STOCK TITAN

[Form 4] Third Harmonic Bio, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Third Harmonic Bio, Inc. (THRD) filed a Form 4 showing that director Hans Martin Seidel disposed of all his equity holdings in connection with the company's dissolution. On 08/11/2025 Seidel's 85,753 shares of common stock were cancelled and he received a liquidation distribution of $5.35 per share. In addition, 53,090 stock options were treated as exercised/cancelled, with the cash payment equal to the $5.35 per share liquidation amount less the options' exercise price. Following these transactions the reporting person holds 0 shares and 0 derivative securities.

Third Harmonic Bio, Inc. (THRD) ha presentato un Modulo 4 che indica che il consigliere Hans Martin Seidel ha ceduto tutte le sue partecipazioni azionarie in relazione alla liquidazione della società. In data 11/08/2025 le sue 85.753 azioni ordinarie sono state annullate e gli è stata corrisposta una distribuzione di liquidazione di $5,35 per azione. Inoltre, 53.090 opzioni su azioni sono state considerate esercitate/annullate, con il pagamento in contanti pari al $5,35 per azione di liquidazione al netto del prezzo di esercizio delle opzioni. A seguito di queste operazioni la persona segnalante non detiene più 0 azioni né strumenti derivati.

Third Harmonic Bio, Inc. (THRD) presentó un Formulario 4 que muestra que el director Hans Martin Seidel se desprendió de todas sus participaciones accionarias en relación con la disolución de la compañía. El 11/08/2025 las 85.753 acciones ordinarias de Seidel fueron canceladas y recibió una distribución de liquidación de $5,35 por acción. Además, 53.090 opciones sobre acciones fueron tratadas como ejercidas/canceladas, con el pago en efectivo igual al $5,35 por acción de liquidación menos el precio de ejercicio de las opciones. Tras estas transacciones, la persona informante posee 0 acciones y 0 valores derivados.

Third Harmonic Bio, Inc. (THRD)는 이사 한스 마틴 자이델(Hans Martin Seidel)이 회사 해산과 관련해 모든 지분을 처분했다는 내용을 담은 Form 4를 제출했습니다. 2025년 8월 11일 자이델의 보통주 85,753주는 소각되었고 주당 $5.35의 청산 배당금을 받았습니다. 또한 53,090개의 주식옵션은 행사/취소로 처리되었으며 현금 지급액은 옵션 행사가를 차감한 주당 $5.35의 청산 금액입니다. 이 거래들 이후 해당 보고인은 0주 및 0개의 파생증권을 보유하고 있습니다.

Third Harmonic Bio, Inc. (THRD) a déposé un formulaire 4 indiquant que l'administrateur Hans Martin Seidel a cédé l'ensemble de ses participations dans le cadre de la dissolution de la société. Le 11/08/2025, les 85 753 actions ordinaires de Seidel ont été annulées et il a reçu une distribution de liquidation de 5,35 $ par action. De plus, 53 090 options d'achat d'actions ont été considérées comme exercées/annulées, le paiement en espèces correspondant au montant de liquidation de 5,35 $ par action diminué du prix d'exercice des options. À la suite de ces opérations, la personne déclarée ne détient plus 0 action ni de titres dérivés.

Third Harmonic Bio, Inc. (THRD) reichte ein Formular 4 ein, aus dem hervorgeht, dass Direktor Hans Martin Seidel alle seine Aktienbestände im Zusammenhang mit der Auflösung des Unternehmens veräußert hat. Am 11.08.2025 wurden Seidels 85.753 Stammaktien annulliert und ihm wurde eine Liquidationsausschüttung in Höhe von $5,35 pro Aktie ausgezahlt. Außerdem wurden 53.090 Aktienoptionen als ausgeübt/annulliert behandelt, wobei die Barzahlung dem $5,35 pro Aktie Liquidationsbetrag abzüglich des Ausübungspreises der Optionen entsprach. Nach diesen Transaktionen hält die meldende Person 0 Aktien und 0 Derivatwerte.

Positive
  • Liquidation distribution of $5.35 per share provided cash value to the reporting person
  • All holdings settled, removing ongoing insider uncertainty about unexercised options or residual shares
Negative
  • Issuer dissolution as stated in the explanation indicates termination of the company as an operating equity issuer
  • Reporting person now owns 0 shares and 0 derivatives, showing full exit of insider holdings

Insights

TL;DR: The Form 4 records a full equity exit tied to issuer dissolution and a per-share liquidation payout of $5.35.

The filing documents a governance-level outcome: the company underwent dissolution triggering cancellation of common stock and option settlements for insiders. That process transfers residual value to holders via a fixed liquidation distribution rather than ongoing equity. For remaining public investors this is a definitive corporate wind-up event with material consequences for equity value and voting rights. The transaction is procedural but highly material because it ends the company as an operating equity issuer.

TL;DR: Insider received cash of $5.35 per cancelled share; all reported holdings reduced to zero.

The statement quantifies the liquidation payout and shows the mechanics: cancellation of 85,753 shares and settlement of 53,090 option units resulting in cash equal to $5.35 per share less any option exercise price. From a securities perspective, this removes outstanding interest from the reporting person and signals that public equity claims have been extinguished through liquidation distributions.

Third Harmonic Bio, Inc. (THRD) ha presentato un Modulo 4 che indica che il consigliere Hans Martin Seidel ha ceduto tutte le sue partecipazioni azionarie in relazione alla liquidazione della società. In data 11/08/2025 le sue 85.753 azioni ordinarie sono state annullate e gli è stata corrisposta una distribuzione di liquidazione di $5,35 per azione. Inoltre, 53.090 opzioni su azioni sono state considerate esercitate/annullate, con il pagamento in contanti pari al $5,35 per azione di liquidazione al netto del prezzo di esercizio delle opzioni. A seguito di queste operazioni la persona segnalante non detiene più 0 azioni né strumenti derivati.

Third Harmonic Bio, Inc. (THRD) presentó un Formulario 4 que muestra que el director Hans Martin Seidel se desprendió de todas sus participaciones accionarias en relación con la disolución de la compañía. El 11/08/2025 las 85.753 acciones ordinarias de Seidel fueron canceladas y recibió una distribución de liquidación de $5,35 por acción. Además, 53.090 opciones sobre acciones fueron tratadas como ejercidas/canceladas, con el pago en efectivo igual al $5,35 por acción de liquidación menos el precio de ejercicio de las opciones. Tras estas transacciones, la persona informante posee 0 acciones y 0 valores derivados.

Third Harmonic Bio, Inc. (THRD)는 이사 한스 마틴 자이델(Hans Martin Seidel)이 회사 해산과 관련해 모든 지분을 처분했다는 내용을 담은 Form 4를 제출했습니다. 2025년 8월 11일 자이델의 보통주 85,753주는 소각되었고 주당 $5.35의 청산 배당금을 받았습니다. 또한 53,090개의 주식옵션은 행사/취소로 처리되었으며 현금 지급액은 옵션 행사가를 차감한 주당 $5.35의 청산 금액입니다. 이 거래들 이후 해당 보고인은 0주 및 0개의 파생증권을 보유하고 있습니다.

Third Harmonic Bio, Inc. (THRD) a déposé un formulaire 4 indiquant que l'administrateur Hans Martin Seidel a cédé l'ensemble de ses participations dans le cadre de la dissolution de la société. Le 11/08/2025, les 85 753 actions ordinaires de Seidel ont été annulées et il a reçu une distribution de liquidation de 5,35 $ par action. De plus, 53 090 options d'achat d'actions ont été considérées comme exercées/annulées, le paiement en espèces correspondant au montant de liquidation de 5,35 $ par action diminué du prix d'exercice des options. À la suite de ces opérations, la personne déclarée ne détient plus 0 action ni de titres dérivés.

Third Harmonic Bio, Inc. (THRD) reichte ein Formular 4 ein, aus dem hervorgeht, dass Direktor Hans Martin Seidel alle seine Aktienbestände im Zusammenhang mit der Auflösung des Unternehmens veräußert hat. Am 11.08.2025 wurden Seidels 85.753 Stammaktien annulliert und ihm wurde eine Liquidationsausschüttung in Höhe von $5,35 pro Aktie ausgezahlt. Außerdem wurden 53.090 Aktienoptionen als ausgeübt/annulliert behandelt, wobei die Barzahlung dem $5,35 pro Aktie Liquidationsbetrag abzüglich des Ausübungspreises der Optionen entsprach. Nach diesen Transaktionen hält die meldende Person 0 Aktien und 0 Derivatwerte.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Seidel Hans Martin

(Last) (First) (Middle)
C/O THIRD HARMONIC BIO, INC.
1700 MONTGOMERY STREET, SUITE 210

(Street)
SAN FRANCISCO CA 94111

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Third Harmonic Bio, Inc. [ THRD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/11/2025 J(1) 85,753 D (2) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (3) 08/11/2025 J(1) 53,090 (3) (3) Common Stock 53,090 $0 0 D
Explanation of Responses:
1. Transaction reported is a cancellation of shares of common stock in connection with the dissolution of the Issuer.
2. The reporting person received a liquidation distribution of $5.35 per share of Common Stock from Issuer.
3. Represents payment of the liquidation distribution of $5.35 per share less the exercise price of such options.
/s/ Natalie Holles, Attorney-in-Fact 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Hans Martin Seidel report on Form 4 for THRD?

The filing shows Seidel disposed of 85,753 common shares and 53,090 option-related units on 08/11/2025, resulting in 0 shares owned following the transactions.

Why were the shares and options cancelled according to the Form 4?

The Form 4 explains the transactions were cancellations in connection with the dissolution of the Issuer and related liquidation distributions.

How much cash was paid per cancelled share?

The reporting person received a liquidation distribution of $5.35 per share from the issuer.

How were stock options treated in this transaction?

The filing states 53,090 option units were settled with payment equal to the $5.35 per share liquidation amount less the options' exercise price.

What is the transaction date on the Form 4?

The transactions are dated 08/11/2025, and the Form 4 was signed by attorney-in-fact on 08/14/2025.
Third Harmonic Bio Inc

NASDAQ:THRD

THRD Rankings

THRD Latest News

THRD Latest SEC Filings

THRD Stock Data

242.79M
35.24M
9.11%
80.12%
3.15%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO